Uniphos Enterprises Limited Stocks

113.56Last Updated 13.02.2026

Issuer Rating

3/7

Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

₹ 87.27M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
113.56
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Uniphos Enterprises Limited engages in trading of chemicals and other products in India. The company also invests in quoted and unquoted securities. Uniphos Enterprises Limited was incorporated in 1969 and is based in Mumbai, India. Uniphos Enterprises Limited is a subsidiary of Nerka Chemicals Private Limited.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is 'expensive' on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks